Jalil Charmi

766 total citations
17 papers, 637 citations indexed

About

Jalil Charmi is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry. According to data from OpenAlex, Jalil Charmi has authored 17 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 10 papers in Biomaterials and 10 papers in Materials Chemistry. Recurrent topics in Jalil Charmi's work include Nanoplatforms for cancer theranostics (12 papers), Nanoparticle-Based Drug Delivery (10 papers) and Nanocluster Synthesis and Applications (5 papers). Jalil Charmi is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Nanoparticle-Based Drug Delivery (10 papers) and Nanocluster Synthesis and Applications (5 papers). Jalil Charmi collaborates with scholars based in Iran, Türkiye and China. Jalil Charmi's co-authors include Hamed Nosrati, Hossein Danafar, Soodabeh Davaran, Marziyeh Salehiabar, Fatemeh Abhari, Mohammadreza Ghaffarlou, Hamed Rezaeejam, Yavuz Nuri Ertaş, Reza Abbasi and Saeed Kaboli and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and International Journal of Biological Macromolecules.

In The Last Decade

Jalil Charmi

17 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jalil Charmi Iran 13 331 269 197 194 82 17 637
Xiali Zhu China 14 384 1.2× 244 0.9× 145 0.7× 187 1.0× 65 0.8× 32 615
Navid Mousazadeh Iran 13 268 0.8× 196 0.7× 136 0.7× 115 0.6× 65 0.8× 18 513
Die Jia China 13 377 1.1× 310 1.2× 170 0.9× 126 0.6× 68 0.8× 14 595
Sameer Quazi India 5 338 1.0× 310 1.2× 224 1.1× 169 0.9× 46 0.6× 12 713
Zeying Liu China 15 433 1.3× 308 1.1× 225 1.1× 200 1.0× 80 1.0× 30 804
Hai Yang China 13 361 1.1× 192 0.7× 223 1.1× 135 0.7× 58 0.7× 27 646
Liya Xie China 15 378 1.1× 508 1.9× 258 1.3× 120 0.6× 48 0.6× 23 743
Zhichun Shen China 9 250 0.8× 244 0.9× 235 1.2× 88 0.5× 48 0.6× 11 533
Hassan Mellatyar Iran 11 207 0.6× 214 0.8× 316 1.6× 157 0.8× 42 0.5× 17 761

Countries citing papers authored by Jalil Charmi

Since Specialization
Citations

This map shows the geographic impact of Jalil Charmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jalil Charmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jalil Charmi more than expected).

Fields of papers citing papers by Jalil Charmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jalil Charmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jalil Charmi. The network helps show where Jalil Charmi may publish in the future.

Co-authorship network of co-authors of Jalil Charmi

This figure shows the co-authorship network connecting the top 25 collaborators of Jalil Charmi. A scholar is included among the top collaborators of Jalil Charmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jalil Charmi. Jalil Charmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nosrati, Hamed, et al.. (2024). Bismuth-gold nanohybrid based nano photosensitizer to combat antimicrobial resistance. Scientific Reports. 14(1). 22598–22598. 2 indexed citations
2.
Charmi, Jalil, Farzad Seidi, Mohammadreza Ghaffarlou, et al.. (2023). Synthesis of Pt nanoparticles with gelatin-assisted green route to improve sensitization of cancer cells to X-Ray irradiation. International Journal of Pharmaceutics. 643. 123148–123148. 7 indexed citations
3.
Ghaffarlou, Mohammadreza, Ali Mohammadi, Navid Mousazadeh, et al.. (2023). Facile preparation of silver based radiosensitizers via biomineralization method for enhanced in vivo breast cancer radiotherapy. Scientific Reports. 13(1). 15131–15131. 10 indexed citations
4.
Rashidzadeh, Hamid, Farzad Seidi, Mohammadreza Ghaffarlou, et al.. (2023). Preparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor. International Journal of Biological Macromolecules. 233. 123273–123273. 31 indexed citations
5.
Nosrati, Hamed, Marziyeh Salehiabar, Jalil Charmi, et al.. (2023). Enhanced In Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles. ACS Applied Bio Materials. 6(2). 784–792. 50 indexed citations
6.
Nosrati, Hamed, Marziyeh Salehiabar, Jalil Charmi, et al.. (2022). Preparation and evaluation of bismuth sulfide and magnetite‐based theranostic nanohybrid as drug carrier and dual MRI/CT contrast agent. Applied Organometallic Chemistry. 36(11). 25 indexed citations
7.
Nosrati, Hamed, Hamed Rezaeejam, Jalil Charmi, et al.. (2020). Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line. International Journal of Pharmaceutics. 582. 119320–119320. 40 indexed citations
8.
Abhari, Fatemeh, Jalil Charmi, Hamed Rezaeejam, et al.. (2020). Folic Acid Modified Bismuth Sulfide and Gold Heterodimers for Enhancing Radiosensitization of Mice Tumors to X-ray Radiation. ACS Sustainable Chemistry & Engineering. 8(13). 5260–5269. 44 indexed citations
9.
Rahimi, Hossein, Marziyeh Salehiabar, Jalil Charmi, et al.. (2020). Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system. Nano Today. 34. 100895–100895. 62 indexed citations
10.
Nosrati, Hamed, Jalil Charmi, Fatemeh Abhari, et al.. (2020). Improved synergic therapeutic effects of chemoradiation therapy with the aid of a co-drug-loaded nano-radiosensitizer under conventional-dose X-ray irradiation. Biomaterials Science. 8(15). 4275–4286. 24 indexed citations
11.
Nosrati, Hamed, Fatemeh Abhari, Jalil Charmi, Soodabeh Davaran, & Hossein Danafar. (2019). Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery. Bioorganic Chemistry. 88. 102959–102959. 26 indexed citations
12.
Nosrati, Hamed, Jalil Charmi, Marziyeh Salehiabar, Fatemeh Abhari, & Hossein Danafar. (2019). Tumor Targeted Albumin Coated Bismuth Sulfide Nanoparticles (Bi2S3) as Radiosensitizers and Carriers of Curcumin for Enhanced Chemoradiation Therapy. ACS Biomaterials Science & Engineering. 5(9). 4416–4424. 51 indexed citations
13.
Charmi, Jalil, et al.. (2019). Polyethylene glycol (PEG) decorated graphene oxide nanosheets for controlled release curcumin delivery. Heliyon. 5(4). e01466–e01466. 89 indexed citations
14.
Nosrati, Hamed, Shayesteh Bochani, Jalil Charmi, et al.. (2019). Glutathione (GSH) Peptide Conjugated Magnetic Nanoparticles As Blood–Brain Barrier Shuttle for MRI-Monitored Brain Delivery of Paclitaxel. ACS Biomaterials Science & Engineering. 5(4). 1677–1685. 54 indexed citations
15.
Nosrati, Hamed, Fatemeh Abhari, Jalil Charmi, et al.. (2019). Facile green synthesis of bismuth sulfide radiosensitizer via biomineralization of albumin natural molecule for chemoradiation therapy aim. Artificial Cells Nanomedicine and Biotechnology. 47(1). 3832–3838. 14 indexed citations
16.
Nosrati, Hamed, et al.. (2018). Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells. International Journal of Biological Macromolecules. 117. 1125–1132. 99 indexed citations
17.
Nosrati, Hamed, Jalil Charmi, Elahe Attari, et al.. (2018). Preparation and characterization of magnetic theranostic nanoparticles for curcumin delivery and evaluation as MRI contrast agent. Applied Organometallic Chemistry. 32(12). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026